跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TongXinLuo
首页
药物
TongXinLuo
TongXinLuo
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Supermicro heart-meridians-activating Chinese medicine composition and its preparing method
CN 1709291 A
申请人: HEBEI YILING MEDICINE INST CO
优先权: 2004
CN
Orally disintegrating tablet of 'Tongxinluo' and its preparation
CN 1593623 A
申请人: ZHANG QINGLONG
优先权: 2004
CN
Supermicro Tongxinluo Chinese herbal composite and its new usage
CN 1954825 B
申请人: PHARMACEUTICAL RES INST OF YILING PHARMACEUTICAL GROUP CO LTD
优先权: 2005
CN
Application of Tongxinluo in preparation of medicine for inhibiting ferroptosis
CN 115998801 A
申请人: HEBEI YILING MEDICINE INST CO
优先权: 2021
CN
Application of enalapril maleate-folic acid tablets and Tongxinluo in preparation of medicine for treating hypertension complicated with carotid arteriosclerosis
CN 115501224 A
申请人: THE FIRST AFFILIATED HOSPITAL OF NANCHANG UNIV
优先权: 2022
CN
Application of Tongxinluo in preparation of medicine capable of activating or enhancing PERK-eIF2alpha-ATF4 signal channel
CN 120501788 A
申请人: FUWAI HOSPITAL CAMS
优先权: 2025
CN
药物
反馈